Marcela E. Donadio
Known title: DirectorCIK: 0001604594
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
NOV Inc. Faces Mixed Analyst Views Amid Energy Route Tightening. NOV Inc. is in the news as analysts discuss its valuation and the impact of tighter energy trade routes. Citigroup lowered its target price to $21, citing concerns that the company may not benefit from the pricing power seen in other oil and gas peers. A recent Yahoo piece highlighted three reasons to avoid NOV, while another article noted that some peers are gaining from tighter routes. The stock sits near a 200‑day moving‑average support at $18.50 and an RSI of 38.3, indicating a neutral technical stance.
Transaction History
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| NOV | ▲ Buy | Grant | 9,457 | $0 | 5/20/2026 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| NOV | ▲ Buy | Grant | 15,949 | $0 | 5/20/2025 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| NOV | ▲ Buy | Grant | 9,550 | $0 | 5/15/2024 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| NOV | ▲ Buy | Grant | 12,000 | $0 | 5/17/2023 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| NOV | ▲ Buy | Grant | 8,473 | $0 | 5/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.